Pages that link to "Q37288757"
Jump to navigation
Jump to search
The following pages link to Characteristics of gastrointestinal symptoms and function following endoscopic submucosal dissection and treatment of the gastrointestinal symptoms using rikkunshito (Q37288757):
Displaying 9 items.
- Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome (Q34669261) (← links)
- Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract (Q35030764) (← links)
- Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer (Q36921950) (← links)
- Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: a systematic review (Q37691031) (← links)
- Predictive Factors for Pain After Endoscopic Resection of Gastric Tumors. (Q39166527) (← links)
- Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study (Q41605478) (← links)
- Keishibukuryogan, a Traditional Japanese Medicine, Inhibits Platelet Aggregation in Guinea Pig Whole Blood (Q43115828) (← links)
- Endoscopic submucosal dissection for early gastric cancer on the lesser curvature in upper third of the stomach is a risk factor for postoperative delayed gastric emptying. (Q50126520) (← links)
- Clinicopathological characteristics of patients with pain after endoscopic submucosal dissection for gastric epithelial neoplasm (Q90265432) (← links)